{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:18:20Z","timestamp":1781885900104,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100019346","name":"Instituto Nacional de Cancerolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["5437"],"award-info":[{"award-number":["5437"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1136\/ijgc-2023-005190","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:55:15Z","timestamp":1709772915000},"page":"1020-1026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3870-2182","authenticated-orcid":false,"given":"Erica M","family":"Bednar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiry A","family":"Paiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Patricia","family":"Soares Dias De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos e Eduardo Mattos da Cunha","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenny","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo","family":"Rubio-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0229-7931","authenticated-orcid":false,"given":"David","family":"Cantu-de-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Alejandro","family":"Rauh-Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-005190_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00338","article-title":"Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer","volume":"3","author":"Cadoo","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0020","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0025","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":"Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res"},{"key":"10.1136\/ijgc-2023-005190_bb0030","author":"National Comprehensive Cancer Network","year":"2007","journal-title":"Genetic\/familial high-risk assessment: breast and ovarian. NCCN clinical practice guidelines in oncology"},{"key":"10.1136\/ijgc-2023-005190_bb0035","author":"National Comprehensive Cancer Network","year":"2019","journal-title":"Genetic\/familial high-risk assessment: colorectal. NCCN clinical practice guidelines in oncology (NCCN guidelines)"},{"key":"10.1136\/ijgc-2023-005190_bb0040","author":"The Society of Gynecologic Oncology","year":"2014","journal-title":"SGO clinical practice statement: screening for Lynch syndrome in endometrial cancer, 2018"},{"key":"10.1136\/ijgc-2023-005190_bb0045","doi-asserted-by":"crossref","first-page":"104350","DOI":"10.1016\/j.ejmg.2021.104350","article-title":"Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe","volume":"64","author":"Marmolejo","year":"2021","journal-title":"Eur J Med Genet"},{"key":"10.1136\/ijgc-2023-005190_bb0050","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.healthpol.2021.04.010","article-title":"Utilization and uptake of clinical genetics services in high-income countries: a scoping review","volume":"125","author":"Dragojlovic","year":"2021","journal-title":"Health Policy"},{"key":"10.1136\/ijgc-2023-005190_bb0055","author":"World Health Organization","year":"2011","journal-title":"Community genetics services: report of a WHO consultation on community genetics in low- and middle-income countries"},{"key":"10.1136\/ijgc-2023-005190_bb0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ajmg.c.31607","article-title":"Genetic counseling globally: where are we now","volume":"178","author":"Ormond","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1136\/ijgc-2023-005190_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1200\/JGO.19.00170","article-title":"Recommendations for advancing the diagnosis and management of hereditary breast and ovarian cancer in Brazil","volume":"6","author":"Achatz","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0070","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s00268-018-04897-6","article-title":"Global disparities in breast cancer genetics testing, counselling and management","volume":"43","author":"Yip","year":"2019","journal-title":"World J Surg"},{"key":"10.1136\/ijgc-2023-005190_bb0075","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/ejhg.2014.180","article-title":"A systematic review of factors that act as barriers to patient referral to genetic services","volume":"23","author":"Delikurt","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1136\/ijgc-2023-005190_bb0080","doi-asserted-by":"crossref","first-page":"100275","DOI":"10.1016\/j.jcpo.2021.100275","article-title":"Cancer genetic testing in marginalized groups during an era of evolving healthcare reform","volume":"28","author":"Modell","year":"2021","journal-title":"J Cancer Policy"},{"key":"10.1136\/ijgc-2023-005190_bb0085","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.20.02785","article-title":"Time trends in receipt of germline genetic testing and results for women diagnosed with breast cancer or ovarian cancer, 2012-2019","volume":"39","author":"Kurian","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.42703","article-title":"Use of germline BRCA testing in patients with ovarian cancer and commercial insurance","volume":"5","author":"Cham","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1136\/ijgc-2023-005190_bb0095","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1158\/1940-6207.CAPR-21-0073","article-title":"Uptake of genetic testing among patients with cancer at risk for Lynch syndrome in the National Health Interview Survey","volume":"14","author":"Actkins","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1136\/ijgc-2023-005190_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2023.9526","article-title":"Germline genetic testing after cancer diagnosis","volume":"330","author":"Kurian","year":"2023","journal-title":"JAMA"},{"key":"10.1136\/ijgc-2023-005190_bb0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1136\/ijgc-2023-005190_bb0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2023.03.016","article-title":"Outcomes of the \"BRCA Quality Improvement Dissemination Program\": an initiative to improve patient receipt of cancer genetics services at five health systems","volume":"172","author":"Bednar","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ygyno.2017.05.037","article-title":"A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment","volume":"146","author":"Bednar","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","article-title":"Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities","volume":"115","author":"Meyer","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-005190_bb0125","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ygyno.2023.06.467","article-title":"Now: neoadjuvant olaparib window trial in patients with newly diagnosed BRCA mutant ovarian cancer (LBA 1)","volume":"176","author":"Westin","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2966-x","article-title":"Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil","volume":"16","author":"Maistro","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1136\/ijgc-2023-005190_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3233\/BD-210082","article-title":"Genetic testing for hereditary predisposition to breast cancer in the real world: initial experience","volume":"41","author":"da Silva Fontinele","year":"2022","journal-title":"Breast Dis"},{"key":"10.1136\/ijgc-2023-005190_bb0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10549-023-06909-z","article-title":"Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients","volume":"199","author":"Acevedo","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1136\/ijgc-2023-005190_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/genes9070349","article-title":"Description of genetic variants in BRCA genes in Mexican patients with ovarian cancer: a first step towards implementing personalized medicine","volume":"9","author":"Delgado-Balderas","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1136\/ijgc-2023-005190_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ygyno.2018.12.001","article-title":"Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic","volume":"152","author":"Bednar","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2015.01.535","article-title":"Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing","volume":"137","author":"Frolova","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ygyno.2020.10.016","article-title":"Universal screening for Lynch syndrome in uterine cancer patients: a quality improvement initiative","volume":"160","author":"Spinosa","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/1940-6207.CAPR-16-0219","article-title":"Clinical challenges associated with universal screening for Lynch syndrome-associated endometrial cancer","volume":"10","author":"Bruegl","year":"2017","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1136\/ijgc-2023-005190_bb0170","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/gim.2017.39","article-title":"Identifying \u201cownership\u201d through role descriptions to support implementing universal colorectal cancer tumor screening for Lynch syndrome","volume":"19","author":"West","year":"2017","journal-title":"Genet Med"},{"key":"10.1136\/ijgc-2023-005190_bb0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2020.07.013","article-title":"Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach","volume":"159","author":"Rosa","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10689-009-9297-x","article-title":"Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil","volume":"9","author":"Cossio","year":"2010","journal-title":"Fam Cancer"},{"key":"10.1136\/ijgc-2023-005190_bb0185","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejca.2019.07.017","article-title":"A snapshot of current genetic testing practice in Lynch syndrome: the results of a representative survey of 33 Latin American existing centres\/registries","volume":"119","author":"Della Valle","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2023-005190_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12687-021-00549-w","article-title":"When guidelines face reality - Lynch syndrome screening in the setting of public health system in a developing country","volume":"13","author":"Kozak","year":"2022","journal-title":"J Community Genet"},{"key":"10.1136\/ijgc-2023-005190_bb0195","article-title":"Conceptualizing learning health systems: a mapping review","volume":"7","author":"de Bruin","year":"2023","journal-title":"Learn Health Syst"},{"key":"10.1136\/ijgc-2023-005190_bb0200","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.gim.2022.03.002","article-title":"Interventions to improve delivery of cancer genetics services in the United States: a scoping review","volume":"24","author":"Bednar","year":"2022","journal-title":"Genet Med"},{"key":"10.1136\/ijgc-2023-005190_bb0205","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2217\/fon-2020-1152","article-title":"FLABRA, frontline approach for BRCA testing in an ovarian cancer population: a Latin America epidemiologic study","volume":"17","author":"Giornelli","year":"2021","journal-title":"Future Oncol"},{"key":"10.1136\/ijgc-2023-005190_bb0210","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1200\/JCO.19.02960","article-title":"Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline","volume":"38","author":"Konstantinopoulos","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24014385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24014385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-005190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:57:29Z","timestamp":1762354649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24014385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1048891X24014385"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-005190","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-005190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}